Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 175619, 6 pages
http://dx.doi.org/10.1155/2012/175619
Research Article

Tramadol Pretreatment Enhances Ketamine-Induced Antidepressant Effects and Increases Mammalian Target of Rapamycin in Rat Hippocampus and Prefrontal Cortex

1Department of Anesthesiology, School of Medicine, Jinling Hospital, Nanjing University, No. 305 East Zhongshan Road, Jiangsu Nanjing 210002, China
2Department of Anesthesiology, Affiliated Drum-Tower Hospital of Medical College of Nanjing University, No. 321 Zhongshan Road, Jiangsu Nanjing 210008, China
3The PLA 102nd Hospital and Mental Health Center of Military, No. 55 North Heping Road, Jiangsu Changzhou 213000, China

Received 14 January 2012; Revised 6 February 2012; Accepted 8 February 2012

Academic Editor: Daniel T. Monaghan

Copyright © 2012 Chun Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Diazgranados, L. Ibrahim, N. E. Brutsche et al., “A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression,” Archives of General Psychiatry, vol. 67, no. 8, pp. 793–802, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Machado-Vieira, G. Salvadore, N. DiazGranados, and C. A. Zarate Jr, “Ketamine and the next generation of antidepressants with a rapid onset of action,” Pharmacology and Therapeutics, vol. 123, no. 2, pp. 143–150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Skolnick, P. Popik, and R. Trullas, “Glutamate-based antidepressants: 20 years on,” Trends in Pharmacological Sciences, vol. 30, no. 11, pp. 563–569, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. C. A. Zarate Jr, J. B. Singh, P. J. Carlson et al., “A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression,” Archives of General Psychiatry, vol. 63, no. 8, pp. 856–864, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. aan het Rot, K. A. Collins, J. W. Murrough et al., “Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression,” Biological Psychiatry, vol. 67, no. 2, pp. 139–145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. N. DiazGranados, L. A. Ibrahim, N. E. Brutsche et al., “Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder,” Journal of Clinical Psychiatry, vol. 71, no. 12, pp. 1605–1611, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Liebrenz, A. Borgeat, R. Leisinger, and R. Stohler, “Intravenous ketamine therapy in a patient with a treatment-resistant major depression,” Swiss Medical Weekly, vol. 137, no. 15-16, pp. 234–236, 2007. View at Google Scholar · View at Scopus
  8. C. Zarate Jr, R. MacHado-Vieira, I. Henter, L. Ibrahim, N. Diazgranados, and G. Salvadore, “Glutamatergic modulators: the future of treating mood disorders,” Harvard Review of Psychiatry, vol. 18, no. 5, pp. 293–303, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. B. Price, M. K. Nock, D. S. Charney, and S. J. Mathew, “Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression,” Biological Psychiatry, vol. 66, no. 5, pp. 522–526, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. R. S. Duman, N. Li, R. -J. Liu, V. Duric, and G. Aghajanian, “Signaling pathways underlying the rapid antidepressant actions of ketamine,” Neuropharmacology, vol. 62, no. 1, pp. 35–41, 2012. View at Publisher · View at Google Scholar
  11. K. Hashimoto, “Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine,” Expert Review of Neurotherapeutics, vol. 11, no. 1, pp. 33–36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Li, B. Lee, R. J. Liu et al., “mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists,” Science, vol. 329, no. 5994, pp. 959–964, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. C. Denk, C. Rewerts, F. Holsboer, A. Erhardt-Lehmann, and C. W. Turck, “Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation,” American Journal of Psychiatry, vol. 168, no. 7, pp. 751–752, 2011. View at Publisher · View at Google Scholar
  14. C. S. Jernigan, D. B. Goswami, M. C. Austin et al., “The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 35, no. 7, pp. 1774–1779, 2011. View at Publisher · View at Google Scholar
  15. J. Barber, “Examining the Use of Tramadol Hydrochloride as an Antidepressant,” Experimental and Clinical Psychopharmacology, vol. 19, no. 2, pp. 123–130, 2011. View at Publisher · View at Google Scholar
  16. M. N. M. de Lima, D. C. Laranja, F. Caldana et al., “Selegiline protects against recognition memory impairment induced by neonatal iron treatment,” Experimental Neurology, vol. 196, no. 1, pp. 177–183, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. J. Detke, J. Johnson, and I. Lucki, “Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression,” Experimental and Clinical Psychopharmacology, vol. 5, no. 2, pp. 107–112, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Nishimura, K. Sato, T. Okada et al., “Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells,” Anesthesiology, vol. 88, no. 3, pp. 768–774, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. R. R. Reeves and R. S. Burke, “Tramadol: basic pharmacology and emerging concepts,” Drugs of Today, vol. 44, no. 11, pp. 827–836, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Wang, Y. Yang, X. Zhou et al., “Propofol pretreatment increases antidepressant-like effects induced by acute administration of ketamine in rats receiving forced swimming test,” Psychiatry Research, vol. 185, no. 1-2, pp. 248–253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Z. Réus, R. B. Stringari, K. F. Ribeiro et al., “Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain,” Behavioural Brain Research, vol. 221, no. 1, pp. 166–171, 2011. View at Publisher · View at Google Scholar